tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Carter Gould, 115 are a BUY (54.76%), 72 are a HOLD (34.29%), 23 are a SELL (10.95%).
Analyst Carter Gould, currently employed at BARCLAYS, carries an average stock price target met ratio of 68.93% that have a potential upside of 23.98% achieved within 216 days.
Carter Gould’s has documented 433 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TVTX, Travere Therapeutics at 01-Oct-2024.
Analyst best performing recommendations are on APLT (APPLIED THERAPEUTICS).
The best stock recommendation documented was for APLT (APPLIED THERAPEUTICS) at 3/21/2022. The price target of $2.5 was fulfilled within 3 days with a profit of $0.67 (36.61%) receiving and performance score of 122.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$209
$15.24 (7.87%)
$190
1 months 16 days ago
40/41 (97.56%)
$11.45 (5.80%)
477
Buy
$218
$24.24 (12.51%)
$196
1 months 27 days ago
12/13 (92.31%)
$27.82 (14.63%)
488
Buy
$200
$6.24 (3.22%)
$200
2 months 4 days ago
0/5 (0%)
$15.64 (8.48%)
Buy
$205
$11.24 (5.80%)
$180
2 months 13 days ago
4/6 (66.67%)
$19.84 (10.72%)
498
Buy
$210
$16.24 (8.38%)
$195
2 months 13 days ago
10/11 (90.91%)
$24.84 (13.42%)
426
Which stock is Carter Gould is most bullish on?
Which stock is Carter Gould is most reserved on?
What Year was the first public recommendation made by Carter Gould?
